nodes	percent_of_prediction	percent_of_DWPC	metapath
Ciprofloxacin—TOP2A—Epirubicin—testicular cancer	0.152	0.209	CbGbCtD
Ciprofloxacin—TOP2A—Etoposide—testicular cancer	0.118	0.163	CbGbCtD
Ciprofloxacin—TOP2A—Doxorubicin—testicular cancer	0.0806	0.111	CbGbCtD
Ciprofloxacin—CYP3A7—Ifosfamide—testicular cancer	0.0677	0.0936	CbGbCtD
Ciprofloxacin—CYP3A7-CYP3A51P—Ifosfamide—testicular cancer	0.0677	0.0936	CbGbCtD
Ciprofloxacin—CYP3A5—Ifosfamide—testicular cancer	0.0508	0.0702	CbGbCtD
Ciprofloxacin—ABCB1—Dactinomycin—testicular cancer	0.028	0.0387	CbGbCtD
Ciprofloxacin—CYP3A5—Etoposide—testicular cancer	0.0243	0.0335	CbGbCtD
Ciprofloxacin—CYP3A4—Ifosfamide—testicular cancer	0.0198	0.0274	CbGbCtD
Ciprofloxacin—CYP1A2—Etoposide—testicular cancer	0.0181	0.025	CbGbCtD
Ciprofloxacin—ABCB1—Vinblastine—testicular cancer	0.0175	0.0242	CbGbCtD
Ciprofloxacin—ABCB1—Cisplatin—testicular cancer	0.0161	0.0222	CbGbCtD
Ciprofloxacin—ABCB1—Etoposide—testicular cancer	0.0158	0.0218	CbGbCtD
Ciprofloxacin—ABCB1—Doxorubicin—testicular cancer	0.0108	0.0149	CbGbCtD
Ciprofloxacin—CYP3A4—Vinblastine—testicular cancer	0.0105	0.0145	CbGbCtD
Ciprofloxacin—ABCB1—Methotrexate—testicular cancer	0.0104	0.0144	CbGbCtD
Ciprofloxacin—CYP3A4—Etoposide—testicular cancer	0.00947	0.0131	CbGbCtD
Ciprofloxacin—CYP3A4—Doxorubicin—testicular cancer	0.00646	0.00892	CbGbCtD
Ciprofloxacin—TOP2A—Vindesine—Vinblastine—testicular cancer	0.000985	0.188	CbGdCrCtD
Ciprofloxacin—TOP2A—Vinorelbine—Vinblastine—testicular cancer	0.000622	0.118	CbGdCrCtD
Ciprofloxacin—TOP2A—Podofilox—Etoposide—testicular cancer	0.000621	0.118	CbGdCrCtD
Ciprofloxacin—TOP2A—Teniposide—Etoposide—testicular cancer	0.000621	0.118	CbGdCrCtD
Ciprofloxacin—TOP2A—Vincristine—Vinblastine—testicular cancer	0.000531	0.101	CbGdCrCtD
Ciprofloxacin—TOP2A—Idarubicin—Epirubicin—testicular cancer	0.000324	0.0617	CbGdCrCtD
Ciprofloxacin—TOP2A—Daunorubicin—Epirubicin—testicular cancer	0.000324	0.0617	CbGdCrCtD
Ciprofloxacin—TOP2A—Doxorubicin—Epirubicin—testicular cancer	0.000324	0.0617	CbGdCrCtD
Ciprofloxacin—TOP2A—Epirubicin—Doxorubicin—testicular cancer	0.0003	0.0571	CbGdCrCtD
Ciprofloxacin—TOP2A—Idarubicin—Doxorubicin—testicular cancer	0.0003	0.0571	CbGdCrCtD
Ciprofloxacin—TOP2A—Daunorubicin—Doxorubicin—testicular cancer	0.0003	0.0571	CbGdCrCtD
Ciprofloxacin—Pharyngitis—Epirubicin—testicular cancer	8.27e-05	0.000305	CcSEcCtD
Ciprofloxacin—Cardiac disorder—Methotrexate—testicular cancer	8.26e-05	0.000305	CcSEcCtD
Ciprofloxacin—Sweating—Doxorubicin—testicular cancer	8.23e-05	0.000304	CcSEcCtD
Ciprofloxacin—Urinary tract disorder—Epirubicin—testicular cancer	8.23e-05	0.000304	CcSEcCtD
Ciprofloxacin—Oedema peripheral—Epirubicin—testicular cancer	8.21e-05	0.000303	CcSEcCtD
Ciprofloxacin—Haematuria—Doxorubicin—testicular cancer	8.19e-05	0.000302	CcSEcCtD
Ciprofloxacin—Connective tissue disorder—Epirubicin—testicular cancer	8.19e-05	0.000302	CcSEcCtD
Ciprofloxacin—Urethral disorder—Epirubicin—testicular cancer	8.17e-05	0.000301	CcSEcCtD
Ciprofloxacin—Hepatobiliary disease—Doxorubicin—testicular cancer	8.12e-05	0.0003	CcSEcCtD
Ciprofloxacin—Epistaxis—Doxorubicin—testicular cancer	8.1e-05	0.000299	CcSEcCtD
Ciprofloxacin—Angiopathy—Methotrexate—testicular cancer	8.08e-05	0.000298	CcSEcCtD
Ciprofloxacin—Immune system disorder—Methotrexate—testicular cancer	8.04e-05	0.000297	CcSEcCtD
Ciprofloxacin—Visual impairment—Epirubicin—testicular cancer	8.03e-05	0.000296	CcSEcCtD
Ciprofloxacin—Mediastinal disorder—Methotrexate—testicular cancer	8.02e-05	0.000296	CcSEcCtD
Ciprofloxacin—Agranulocytosis—Doxorubicin—testicular cancer	8.01e-05	0.000296	CcSEcCtD
Ciprofloxacin—Chills—Methotrexate—testicular cancer	7.99e-05	0.000295	CcSEcCtD
Ciprofloxacin—Nausea—Ifosfamide—testicular cancer	7.94e-05	0.000293	CcSEcCtD
Ciprofloxacin—Diarrhoea—Cisplatin—testicular cancer	7.89e-05	0.000291	CcSEcCtD
Ciprofloxacin—Erythema multiforme—Epirubicin—testicular cancer	7.88e-05	0.000291	CcSEcCtD
Ciprofloxacin—Alopecia—Methotrexate—testicular cancer	7.87e-05	0.00029	CcSEcCtD
Ciprofloxacin—Bradycardia—Doxorubicin—testicular cancer	7.85e-05	0.00029	CcSEcCtD
Ciprofloxacin—Mental disorder—Methotrexate—testicular cancer	7.8e-05	0.000288	CcSEcCtD
Ciprofloxacin—Eye disorder—Epirubicin—testicular cancer	7.79e-05	0.000287	CcSEcCtD
Ciprofloxacin—Hypersensitivity—Etoposide—testicular cancer	7.78e-05	0.000287	CcSEcCtD
Ciprofloxacin—Tinnitus—Epirubicin—testicular cancer	7.77e-05	0.000287	CcSEcCtD
Ciprofloxacin—Erythema—Methotrexate—testicular cancer	7.75e-05	0.000286	CcSEcCtD
Ciprofloxacin—Malnutrition—Methotrexate—testicular cancer	7.75e-05	0.000286	CcSEcCtD
Ciprofloxacin—Haemoglobin—Doxorubicin—testicular cancer	7.75e-05	0.000286	CcSEcCtD
Ciprofloxacin—Flushing—Epirubicin—testicular cancer	7.73e-05	0.000285	CcSEcCtD
Ciprofloxacin—Cardiac disorder—Epirubicin—testicular cancer	7.73e-05	0.000285	CcSEcCtD
Ciprofloxacin—Rhinitis—Doxorubicin—testicular cancer	7.73e-05	0.000285	CcSEcCtD
Ciprofloxacin—Hepatitis—Doxorubicin—testicular cancer	7.71e-05	0.000285	CcSEcCtD
Ciprofloxacin—Haemorrhage—Doxorubicin—testicular cancer	7.71e-05	0.000285	CcSEcCtD
Ciprofloxacin—Hypoaesthesia—Doxorubicin—testicular cancer	7.67e-05	0.000283	CcSEcCtD
Ciprofloxacin—Pharyngitis—Doxorubicin—testicular cancer	7.65e-05	0.000282	CcSEcCtD
Ciprofloxacin—Urinary tract disorder—Doxorubicin—testicular cancer	7.61e-05	0.000281	CcSEcCtD
Ciprofloxacin—Oedema peripheral—Doxorubicin—testicular cancer	7.59e-05	0.00028	CcSEcCtD
Ciprofloxacin—Dysgeusia—Methotrexate—testicular cancer	7.59e-05	0.00028	CcSEcCtD
Ciprofloxacin—Asthenia—Etoposide—testicular cancer	7.58e-05	0.00028	CcSEcCtD
Ciprofloxacin—Connective tissue disorder—Doxorubicin—testicular cancer	7.58e-05	0.00028	CcSEcCtD
Ciprofloxacin—Angiopathy—Epirubicin—testicular cancer	7.56e-05	0.000279	CcSEcCtD
Ciprofloxacin—Urethral disorder—Doxorubicin—testicular cancer	7.56e-05	0.000279	CcSEcCtD
Ciprofloxacin—Immune system disorder—Epirubicin—testicular cancer	7.53e-05	0.000278	CcSEcCtD
Ciprofloxacin—Mediastinal disorder—Epirubicin—testicular cancer	7.51e-05	0.000277	CcSEcCtD
Ciprofloxacin—Back pain—Methotrexate—testicular cancer	7.5e-05	0.000277	CcSEcCtD
Ciprofloxacin—Chills—Epirubicin—testicular cancer	7.48e-05	0.000276	CcSEcCtD
Ciprofloxacin—Pruritus—Etoposide—testicular cancer	7.47e-05	0.000276	CcSEcCtD
Ciprofloxacin—Arrhythmia—Epirubicin—testicular cancer	7.44e-05	0.000275	CcSEcCtD
Ciprofloxacin—Visual impairment—Doxorubicin—testicular cancer	7.43e-05	0.000274	CcSEcCtD
Ciprofloxacin—Alopecia—Epirubicin—testicular cancer	7.36e-05	0.000272	CcSEcCtD
Ciprofloxacin—Vomiting—Cisplatin—testicular cancer	7.33e-05	0.00027	CcSEcCtD
Ciprofloxacin—Vision blurred—Methotrexate—testicular cancer	7.3e-05	0.00027	CcSEcCtD
Ciprofloxacin—Mental disorder—Epirubicin—testicular cancer	7.3e-05	0.000269	CcSEcCtD
Ciprofloxacin—Erythema multiforme—Doxorubicin—testicular cancer	7.29e-05	0.000269	CcSEcCtD
Ciprofloxacin—Rash—Cisplatin—testicular cancer	7.27e-05	0.000268	CcSEcCtD
Ciprofloxacin—Dermatitis—Cisplatin—testicular cancer	7.26e-05	0.000268	CcSEcCtD
Ciprofloxacin—Malnutrition—Epirubicin—testicular cancer	7.25e-05	0.000268	CcSEcCtD
Ciprofloxacin—Erythema—Epirubicin—testicular cancer	7.25e-05	0.000268	CcSEcCtD
Ciprofloxacin—Diarrhoea—Etoposide—testicular cancer	7.23e-05	0.000267	CcSEcCtD
Ciprofloxacin—Eye disorder—Doxorubicin—testicular cancer	7.2e-05	0.000266	CcSEcCtD
Ciprofloxacin—Ill-defined disorder—Methotrexate—testicular cancer	7.19e-05	0.000265	CcSEcCtD
Ciprofloxacin—Tinnitus—Doxorubicin—testicular cancer	7.19e-05	0.000265	CcSEcCtD
Ciprofloxacin—Anaemia—Methotrexate—testicular cancer	7.16e-05	0.000264	CcSEcCtD
Ciprofloxacin—Flushing—Doxorubicin—testicular cancer	7.16e-05	0.000264	CcSEcCtD
Ciprofloxacin—Cardiac disorder—Doxorubicin—testicular cancer	7.16e-05	0.000264	CcSEcCtD
Ciprofloxacin—Flatulence—Epirubicin—testicular cancer	7.15e-05	0.000264	CcSEcCtD
Ciprofloxacin—Tension—Epirubicin—testicular cancer	7.12e-05	0.000263	CcSEcCtD
Ciprofloxacin—Dysgeusia—Epirubicin—testicular cancer	7.1e-05	0.000262	CcSEcCtD
Ciprofloxacin—Nervousness—Epirubicin—testicular cancer	7.04e-05	0.00026	CcSEcCtD
Ciprofloxacin—Back pain—Epirubicin—testicular cancer	7.02e-05	0.000259	CcSEcCtD
Ciprofloxacin—Angiopathy—Doxorubicin—testicular cancer	6.99e-05	0.000258	CcSEcCtD
Ciprofloxacin—Malaise—Methotrexate—testicular cancer	6.99e-05	0.000258	CcSEcCtD
Ciprofloxacin—Dizziness—Etoposide—testicular cancer	6.98e-05	0.000258	CcSEcCtD
Ciprofloxacin—Muscle spasms—Epirubicin—testicular cancer	6.97e-05	0.000257	CcSEcCtD
Ciprofloxacin—Immune system disorder—Doxorubicin—testicular cancer	6.96e-05	0.000257	CcSEcCtD
Ciprofloxacin—Vertigo—Methotrexate—testicular cancer	6.96e-05	0.000257	CcSEcCtD
Ciprofloxacin—Mediastinal disorder—Doxorubicin—testicular cancer	6.95e-05	0.000256	CcSEcCtD
Ciprofloxacin—Leukopenia—Methotrexate—testicular cancer	6.94e-05	0.000256	CcSEcCtD
Ciprofloxacin—Chills—Doxorubicin—testicular cancer	6.92e-05	0.000255	CcSEcCtD
Ciprofloxacin—Arrhythmia—Doxorubicin—testicular cancer	6.89e-05	0.000254	CcSEcCtD
Ciprofloxacin—Nausea—Cisplatin—testicular cancer	6.85e-05	0.000253	CcSEcCtD
Ciprofloxacin—Vision blurred—Epirubicin—testicular cancer	6.84e-05	0.000252	CcSEcCtD
Ciprofloxacin—Alopecia—Doxorubicin—testicular cancer	6.81e-05	0.000251	CcSEcCtD
Ciprofloxacin—Cough—Methotrexate—testicular cancer	6.76e-05	0.00025	CcSEcCtD
Ciprofloxacin—Mental disorder—Doxorubicin—testicular cancer	6.75e-05	0.000249	CcSEcCtD
Ciprofloxacin—Ill-defined disorder—Epirubicin—testicular cancer	6.73e-05	0.000248	CcSEcCtD
Ciprofloxacin—Convulsion—Methotrexate—testicular cancer	6.72e-05	0.000248	CcSEcCtD
Ciprofloxacin—Vomiting—Etoposide—testicular cancer	6.71e-05	0.000248	CcSEcCtD
Ciprofloxacin—Erythema—Doxorubicin—testicular cancer	6.71e-05	0.000248	CcSEcCtD
Ciprofloxacin—Malnutrition—Doxorubicin—testicular cancer	6.71e-05	0.000248	CcSEcCtD
Ciprofloxacin—Anaemia—Epirubicin—testicular cancer	6.7e-05	0.000247	CcSEcCtD
Ciprofloxacin—Agitation—Epirubicin—testicular cancer	6.67e-05	0.000246	CcSEcCtD
Ciprofloxacin—Rash—Etoposide—testicular cancer	6.66e-05	0.000246	CcSEcCtD
Ciprofloxacin—Dermatitis—Etoposide—testicular cancer	6.65e-05	0.000246	CcSEcCtD
Ciprofloxacin—Headache—Etoposide—testicular cancer	6.62e-05	0.000244	CcSEcCtD
Ciprofloxacin—Flatulence—Doxorubicin—testicular cancer	6.61e-05	0.000244	CcSEcCtD
Ciprofloxacin—Chest pain—Methotrexate—testicular cancer	6.6e-05	0.000244	CcSEcCtD
Ciprofloxacin—Arthralgia—Methotrexate—testicular cancer	6.6e-05	0.000244	CcSEcCtD
Ciprofloxacin—Myalgia—Methotrexate—testicular cancer	6.6e-05	0.000244	CcSEcCtD
Ciprofloxacin—Tension—Doxorubicin—testicular cancer	6.59e-05	0.000243	CcSEcCtD
Ciprofloxacin—Dysgeusia—Doxorubicin—testicular cancer	6.57e-05	0.000243	CcSEcCtD
Ciprofloxacin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	6.55e-05	0.000242	CcSEcCtD
Ciprofloxacin—Malaise—Epirubicin—testicular cancer	6.54e-05	0.000241	CcSEcCtD
Ciprofloxacin—Discomfort—Methotrexate—testicular cancer	6.52e-05	0.000241	CcSEcCtD
Ciprofloxacin—Nervousness—Doxorubicin—testicular cancer	6.52e-05	0.000241	CcSEcCtD
Ciprofloxacin—Vertigo—Epirubicin—testicular cancer	6.52e-05	0.00024	CcSEcCtD
Ciprofloxacin—Syncope—Epirubicin—testicular cancer	6.5e-05	0.00024	CcSEcCtD
Ciprofloxacin—Leukopenia—Epirubicin—testicular cancer	6.49e-05	0.00024	CcSEcCtD
Ciprofloxacin—Back pain—Doxorubicin—testicular cancer	6.49e-05	0.00024	CcSEcCtD
Ciprofloxacin—Muscle spasms—Doxorubicin—testicular cancer	6.45e-05	0.000238	CcSEcCtD
Ciprofloxacin—Palpitations—Epirubicin—testicular cancer	6.41e-05	0.000237	CcSEcCtD
Ciprofloxacin—Confusional state—Methotrexate—testicular cancer	6.38e-05	0.000235	CcSEcCtD
Ciprofloxacin—Loss of consciousness—Epirubicin—testicular cancer	6.38e-05	0.000235	CcSEcCtD
Ciprofloxacin—Cough—Epirubicin—testicular cancer	6.33e-05	0.000234	CcSEcCtD
Ciprofloxacin—Anaphylactic shock—Methotrexate—testicular cancer	6.33e-05	0.000233	CcSEcCtD
Ciprofloxacin—Vision blurred—Doxorubicin—testicular cancer	6.32e-05	0.000233	CcSEcCtD
Ciprofloxacin—Convulsion—Epirubicin—testicular cancer	6.28e-05	0.000232	CcSEcCtD
Ciprofloxacin—Nausea—Etoposide—testicular cancer	6.27e-05	0.000231	CcSEcCtD
Ciprofloxacin—Hypertension—Epirubicin—testicular cancer	6.26e-05	0.000231	CcSEcCtD
Ciprofloxacin—Ill-defined disorder—Doxorubicin—testicular cancer	6.23e-05	0.00023	CcSEcCtD
Ciprofloxacin—Nervous system disorder—Methotrexate—testicular cancer	6.2e-05	0.000229	CcSEcCtD
Ciprofloxacin—Anaemia—Doxorubicin—testicular cancer	6.2e-05	0.000229	CcSEcCtD
Ciprofloxacin—Thrombocytopenia—Methotrexate—testicular cancer	6.19e-05	0.000229	CcSEcCtD
Ciprofloxacin—Arthralgia—Epirubicin—testicular cancer	6.18e-05	0.000228	CcSEcCtD
Ciprofloxacin—Chest pain—Epirubicin—testicular cancer	6.18e-05	0.000228	CcSEcCtD
Ciprofloxacin—Myalgia—Epirubicin—testicular cancer	6.18e-05	0.000228	CcSEcCtD
Ciprofloxacin—Agitation—Doxorubicin—testicular cancer	6.17e-05	0.000228	CcSEcCtD
Ciprofloxacin—Anxiety—Epirubicin—testicular cancer	6.15e-05	0.000227	CcSEcCtD
Ciprofloxacin—Skin disorder—Methotrexate—testicular cancer	6.14e-05	0.000227	CcSEcCtD
Ciprofloxacin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	6.13e-05	0.000226	CcSEcCtD
Ciprofloxacin—Hyperhidrosis—Methotrexate—testicular cancer	6.12e-05	0.000226	CcSEcCtD
Ciprofloxacin—Discomfort—Epirubicin—testicular cancer	6.1e-05	0.000225	CcSEcCtD
Ciprofloxacin—Malaise—Doxorubicin—testicular cancer	6.05e-05	0.000223	CcSEcCtD
Ciprofloxacin—Dry mouth—Epirubicin—testicular cancer	6.04e-05	0.000223	CcSEcCtD
Ciprofloxacin—Vertigo—Doxorubicin—testicular cancer	6.03e-05	0.000223	CcSEcCtD
Ciprofloxacin—Anorexia—Methotrexate—testicular cancer	6.03e-05	0.000223	CcSEcCtD
Ciprofloxacin—Syncope—Doxorubicin—testicular cancer	6.02e-05	0.000222	CcSEcCtD
Ciprofloxacin—Leukopenia—Doxorubicin—testicular cancer	6.01e-05	0.000222	CcSEcCtD
Ciprofloxacin—Confusional state—Epirubicin—testicular cancer	5.97e-05	0.00022	CcSEcCtD
Ciprofloxacin—Palpitations—Doxorubicin—testicular cancer	5.93e-05	0.000219	CcSEcCtD
Ciprofloxacin—Anaphylactic shock—Epirubicin—testicular cancer	5.92e-05	0.000218	CcSEcCtD
Ciprofloxacin—Oedema—Epirubicin—testicular cancer	5.92e-05	0.000218	CcSEcCtD
Ciprofloxacin—Hypotension—Methotrexate—testicular cancer	5.91e-05	0.000218	CcSEcCtD
Ciprofloxacin—Loss of consciousness—Doxorubicin—testicular cancer	5.9e-05	0.000218	CcSEcCtD
Ciprofloxacin—Cough—Doxorubicin—testicular cancer	5.86e-05	0.000216	CcSEcCtD
Ciprofloxacin—Shock—Epirubicin—testicular cancer	5.82e-05	0.000215	CcSEcCtD
Ciprofloxacin—Convulsion—Doxorubicin—testicular cancer	5.81e-05	0.000215	CcSEcCtD
Ciprofloxacin—Nervous system disorder—Epirubicin—testicular cancer	5.81e-05	0.000214	CcSEcCtD
Ciprofloxacin—Thrombocytopenia—Epirubicin—testicular cancer	5.8e-05	0.000214	CcSEcCtD
Ciprofloxacin—Hypertension—Doxorubicin—testicular cancer	5.79e-05	0.000214	CcSEcCtD
Ciprofloxacin—Tachycardia—Epirubicin—testicular cancer	5.78e-05	0.000213	CcSEcCtD
Ciprofloxacin—Musculoskeletal discomfort—Methotrexate—testicular cancer	5.76e-05	0.000213	CcSEcCtD
Ciprofloxacin—Skin disorder—Epirubicin—testicular cancer	5.75e-05	0.000212	CcSEcCtD
Ciprofloxacin—Hyperhidrosis—Epirubicin—testicular cancer	5.72e-05	0.000211	CcSEcCtD
Ciprofloxacin—Insomnia—Methotrexate—testicular cancer	5.72e-05	0.000211	CcSEcCtD
Ciprofloxacin—Arthralgia—Doxorubicin—testicular cancer	5.71e-05	0.000211	CcSEcCtD
Ciprofloxacin—Chest pain—Doxorubicin—testicular cancer	5.71e-05	0.000211	CcSEcCtD
Ciprofloxacin—Myalgia—Doxorubicin—testicular cancer	5.71e-05	0.000211	CcSEcCtD
Ciprofloxacin—Anxiety—Doxorubicin—testicular cancer	5.69e-05	0.00021	CcSEcCtD
Ciprofloxacin—Paraesthesia—Methotrexate—testicular cancer	5.68e-05	0.00021	CcSEcCtD
Ciprofloxacin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	5.67e-05	0.000209	CcSEcCtD
Ciprofloxacin—Discomfort—Doxorubicin—testicular cancer	5.65e-05	0.000208	CcSEcCtD
Ciprofloxacin—Anorexia—Epirubicin—testicular cancer	5.64e-05	0.000208	CcSEcCtD
Ciprofloxacin—Dyspnoea—Methotrexate—testicular cancer	5.64e-05	0.000208	CcSEcCtD
Ciprofloxacin—Somnolence—Methotrexate—testicular cancer	5.62e-05	0.000208	CcSEcCtD
Ciprofloxacin—Dry mouth—Doxorubicin—testicular cancer	5.59e-05	0.000206	CcSEcCtD
Ciprofloxacin—Dyspepsia—Methotrexate—testicular cancer	5.57e-05	0.000205	CcSEcCtD
Ciprofloxacin—Hypotension—Epirubicin—testicular cancer	5.53e-05	0.000204	CcSEcCtD
Ciprofloxacin—Confusional state—Doxorubicin—testicular cancer	5.52e-05	0.000204	CcSEcCtD
Ciprofloxacin—Decreased appetite—Methotrexate—testicular cancer	5.5e-05	0.000203	CcSEcCtD
Ciprofloxacin—Anaphylactic shock—Doxorubicin—testicular cancer	5.48e-05	0.000202	CcSEcCtD
Ciprofloxacin—Oedema—Doxorubicin—testicular cancer	5.48e-05	0.000202	CcSEcCtD
Ciprofloxacin—Gastrointestinal disorder—Methotrexate—testicular cancer	5.46e-05	0.000202	CcSEcCtD
Ciprofloxacin—Fatigue—Methotrexate—testicular cancer	5.45e-05	0.000201	CcSEcCtD
Ciprofloxacin—Pain—Methotrexate—testicular cancer	5.41e-05	0.0002	CcSEcCtD
Ciprofloxacin—Musculoskeletal discomfort—Epirubicin—testicular cancer	5.39e-05	0.000199	CcSEcCtD
Ciprofloxacin—Shock—Doxorubicin—testicular cancer	5.39e-05	0.000199	CcSEcCtD
Ciprofloxacin—Nervous system disorder—Doxorubicin—testicular cancer	5.37e-05	0.000198	CcSEcCtD
Ciprofloxacin—Thrombocytopenia—Doxorubicin—testicular cancer	5.36e-05	0.000198	CcSEcCtD
Ciprofloxacin—Insomnia—Epirubicin—testicular cancer	5.35e-05	0.000198	CcSEcCtD
Ciprofloxacin—Tachycardia—Doxorubicin—testicular cancer	5.35e-05	0.000197	CcSEcCtD
Ciprofloxacin—Skin disorder—Doxorubicin—testicular cancer	5.32e-05	0.000196	CcSEcCtD
Ciprofloxacin—Paraesthesia—Epirubicin—testicular cancer	5.32e-05	0.000196	CcSEcCtD
Ciprofloxacin—Hyperhidrosis—Doxorubicin—testicular cancer	5.3e-05	0.000195	CcSEcCtD
Ciprofloxacin—Dyspnoea—Epirubicin—testicular cancer	5.28e-05	0.000195	CcSEcCtD
Ciprofloxacin—Somnolence—Epirubicin—testicular cancer	5.26e-05	0.000194	CcSEcCtD
Ciprofloxacin—Anorexia—Doxorubicin—testicular cancer	5.22e-05	0.000193	CcSEcCtD
Ciprofloxacin—Feeling abnormal—Methotrexate—testicular cancer	5.21e-05	0.000192	CcSEcCtD
Ciprofloxacin—Dyspepsia—Epirubicin—testicular cancer	5.21e-05	0.000192	CcSEcCtD
Ciprofloxacin—Gastrointestinal pain—Methotrexate—testicular cancer	5.17e-05	0.000191	CcSEcCtD
Ciprofloxacin—Decreased appetite—Epirubicin—testicular cancer	5.15e-05	0.00019	CcSEcCtD
Ciprofloxacin—Hypotension—Doxorubicin—testicular cancer	5.12e-05	0.000189	CcSEcCtD
Ciprofloxacin—Gastrointestinal disorder—Epirubicin—testicular cancer	5.11e-05	0.000189	CcSEcCtD
Ciprofloxacin—Fatigue—Epirubicin—testicular cancer	5.1e-05	0.000188	CcSEcCtD
Ciprofloxacin—Pain—Epirubicin—testicular cancer	5.06e-05	0.000187	CcSEcCtD
Ciprofloxacin—Constipation—Epirubicin—testicular cancer	5.06e-05	0.000187	CcSEcCtD
Ciprofloxacin—Urticaria—Methotrexate—testicular cancer	5.03e-05	0.000185	CcSEcCtD
Ciprofloxacin—Abdominal pain—Methotrexate—testicular cancer	5e-05	0.000185	CcSEcCtD
Ciprofloxacin—Body temperature increased—Methotrexate—testicular cancer	5e-05	0.000185	CcSEcCtD
Ciprofloxacin—Musculoskeletal discomfort—Doxorubicin—testicular cancer	4.99e-05	0.000184	CcSEcCtD
Ciprofloxacin—Insomnia—Doxorubicin—testicular cancer	4.95e-05	0.000183	CcSEcCtD
Ciprofloxacin—Paraesthesia—Doxorubicin—testicular cancer	4.92e-05	0.000182	CcSEcCtD
Ciprofloxacin—Dyspnoea—Doxorubicin—testicular cancer	4.88e-05	0.00018	CcSEcCtD
Ciprofloxacin—Feeling abnormal—Epirubicin—testicular cancer	4.88e-05	0.00018	CcSEcCtD
Ciprofloxacin—Somnolence—Doxorubicin—testicular cancer	4.87e-05	0.00018	CcSEcCtD
Ciprofloxacin—Gastrointestinal pain—Epirubicin—testicular cancer	4.84e-05	0.000179	CcSEcCtD
Ciprofloxacin—Dyspepsia—Doxorubicin—testicular cancer	4.82e-05	0.000178	CcSEcCtD
Ciprofloxacin—Decreased appetite—Doxorubicin—testicular cancer	4.76e-05	0.000176	CcSEcCtD
Ciprofloxacin—Gastrointestinal disorder—Doxorubicin—testicular cancer	4.73e-05	0.000175	CcSEcCtD
Ciprofloxacin—Fatigue—Doxorubicin—testicular cancer	4.72e-05	0.000174	CcSEcCtD
Ciprofloxacin—Urticaria—Epirubicin—testicular cancer	4.7e-05	0.000174	CcSEcCtD
Ciprofloxacin—Pain—Doxorubicin—testicular cancer	4.68e-05	0.000173	CcSEcCtD
Ciprofloxacin—Constipation—Doxorubicin—testicular cancer	4.68e-05	0.000173	CcSEcCtD
Ciprofloxacin—Abdominal pain—Epirubicin—testicular cancer	4.68e-05	0.000173	CcSEcCtD
Ciprofloxacin—Body temperature increased—Epirubicin—testicular cancer	4.68e-05	0.000173	CcSEcCtD
Ciprofloxacin—Hypersensitivity—Methotrexate—testicular cancer	4.66e-05	0.000172	CcSEcCtD
Ciprofloxacin—Asthenia—Methotrexate—testicular cancer	4.54e-05	0.000167	CcSEcCtD
Ciprofloxacin—Feeling abnormal—Doxorubicin—testicular cancer	4.51e-05	0.000167	CcSEcCtD
Ciprofloxacin—Gastrointestinal pain—Doxorubicin—testicular cancer	4.48e-05	0.000165	CcSEcCtD
Ciprofloxacin—Pruritus—Methotrexate—testicular cancer	4.48e-05	0.000165	CcSEcCtD
Ciprofloxacin—Hypersensitivity—Epirubicin—testicular cancer	4.36e-05	0.000161	CcSEcCtD
Ciprofloxacin—Urticaria—Doxorubicin—testicular cancer	4.35e-05	0.000161	CcSEcCtD
Ciprofloxacin—Body temperature increased—Doxorubicin—testicular cancer	4.33e-05	0.00016	CcSEcCtD
Ciprofloxacin—Abdominal pain—Doxorubicin—testicular cancer	4.33e-05	0.00016	CcSEcCtD
Ciprofloxacin—Diarrhoea—Methotrexate—testicular cancer	4.33e-05	0.00016	CcSEcCtD
Ciprofloxacin—Asthenia—Epirubicin—testicular cancer	4.25e-05	0.000157	CcSEcCtD
Ciprofloxacin—Pruritus—Epirubicin—testicular cancer	4.19e-05	0.000155	CcSEcCtD
Ciprofloxacin—Dizziness—Methotrexate—testicular cancer	4.18e-05	0.000154	CcSEcCtD
Ciprofloxacin—Diarrhoea—Epirubicin—testicular cancer	4.05e-05	0.000149	CcSEcCtD
Ciprofloxacin—Hypersensitivity—Doxorubicin—testicular cancer	4.04e-05	0.000149	CcSEcCtD
Ciprofloxacin—Vomiting—Methotrexate—testicular cancer	4.02e-05	0.000148	CcSEcCtD
Ciprofloxacin—Rash—Methotrexate—testicular cancer	3.99e-05	0.000147	CcSEcCtD
Ciprofloxacin—Dermatitis—Methotrexate—testicular cancer	3.98e-05	0.000147	CcSEcCtD
Ciprofloxacin—Headache—Methotrexate—testicular cancer	3.96e-05	0.000146	CcSEcCtD
Ciprofloxacin—Asthenia—Doxorubicin—testicular cancer	3.93e-05	0.000145	CcSEcCtD
Ciprofloxacin—Dizziness—Epirubicin—testicular cancer	3.91e-05	0.000144	CcSEcCtD
Ciprofloxacin—Pruritus—Doxorubicin—testicular cancer	3.88e-05	0.000143	CcSEcCtD
Ciprofloxacin—Vomiting—Epirubicin—testicular cancer	3.76e-05	0.000139	CcSEcCtD
Ciprofloxacin—Nausea—Methotrexate—testicular cancer	3.76e-05	0.000139	CcSEcCtD
Ciprofloxacin—Diarrhoea—Doxorubicin—testicular cancer	3.75e-05	0.000138	CcSEcCtD
Ciprofloxacin—Rash—Epirubicin—testicular cancer	3.73e-05	0.000138	CcSEcCtD
Ciprofloxacin—Dermatitis—Epirubicin—testicular cancer	3.73e-05	0.000138	CcSEcCtD
Ciprofloxacin—Headache—Epirubicin—testicular cancer	3.71e-05	0.000137	CcSEcCtD
Ciprofloxacin—Dizziness—Doxorubicin—testicular cancer	3.62e-05	0.000134	CcSEcCtD
Ciprofloxacin—Nausea—Epirubicin—testicular cancer	3.52e-05	0.00013	CcSEcCtD
Ciprofloxacin—Vomiting—Doxorubicin—testicular cancer	3.48e-05	0.000129	CcSEcCtD
Ciprofloxacin—Rash—Doxorubicin—testicular cancer	3.45e-05	0.000127	CcSEcCtD
Ciprofloxacin—Dermatitis—Doxorubicin—testicular cancer	3.45e-05	0.000127	CcSEcCtD
Ciprofloxacin—Headache—Doxorubicin—testicular cancer	3.43e-05	0.000127	CcSEcCtD
Ciprofloxacin—Nausea—Doxorubicin—testicular cancer	3.25e-05	0.00012	CcSEcCtD
